Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Major lipids, apolipoproteins, and risk of vascular disease.

Emerging Risk Factors Collaboration., Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J.

JAMA. 2009 Nov 11;302(18):1993-2000. doi: 10.1001/jama.2009.1619.

2.

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Emerging Risk Factors Collaboration., Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J.

JAMA. 2009 Jul 22;302(4):412-23. doi: 10.1001/jama.2009.1063. Review.

3.

Role of lipid and lipoprotein profiles in risk assessment and therapy.

Ballantyne CM, Hoogeveen RC.

Am Heart J. 2003 Aug;146(2):227-33. Review.

PMID:
12891189
4.
5.

Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.

Burgess S, Harshfield E.

Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):124-30. doi: 10.1097/MED.0000000000000230. Review.

6.

Prognostic value of non-high-density lipoprotein cholesterol for mortality in patients with coronary heart disease: A systematic review and meta-analysis.

Liao P, Zeng R, Zhao X, Guo L, Zhang M.

Int J Cardiol. 2017 Jan 15;227:950-955. doi: 10.1016/j.ijcard.2016.10.106. Review.

PMID:
27939140
7.

HDL-cholesterol and cardiac disease: which table to use?

Bayly G.

Ann Clin Biochem. 2002 Jan;39(Pt 1):12-21. Review.

PMID:
11853184

Supplemental Content

Support Center